Clinical Trials Browser

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Locally Advanced Rectal Cancer

Pathologic Complete Response, Rectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Stomach Neoplasms

Carcinoma, Hepatocellular

Pancreatic Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Colonic Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Adenocarcinoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

Lymphoma, Large B-Cell, Diffuse

Stomach Neoplasms

Colonic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Advanced Primary Liver Cancer

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

Rectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colonic Diseases, Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

Clinical Trials

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

CCHOWW

Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer

EASOBFGE

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

ICTCPTLAGC

Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

GASPACCO

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Exploratory Study Of The ERCC-1 Gene

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer

Impact of Adjuvant Chemotherapy in Patients With Colon Cancer

mEGA

ATOM ES

Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer

mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer

Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Focus

Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer

Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

TT

Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation